Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary

Yang‐Min Ning, Richard Pazdur, V. Ellen Maher et al.|Clinical Cancer Research|2013

Cited by 67